Cardiovascular disease (CVD) is the leading cause of death globally and even in developed nations poses a significant health, social and economic burden. More than 10% of the UK population (7.6 million) live with CVD, with an estimated prevalence that is double that of Alzheimer’s disease and cancer combined1.
CVD has been identified as a key target by the UK government, Public Health England, NHS England and NHS Improvement. In an effort to tackle CVD, https://www.longtermplan.nhs.uk/publication/nhs-long-term-plan/ the NHS Long Term Plan has created specific targets in reduction of mortality through CVD risk prevention, with guidance on the importance of collaborative action between stakeholders. COVID-19 has undoubtedly caused huge disruptions in healthcare delivery; however, the front against CVD remains united and lessons have been learnt through the management of this pandemic. With growing support from national organisations, there are reasons for optimism.
As we emerge from the pandemic there is the challenge of dealing with its wider impact on health but also an opportunity to embrace new ways of working2.
During this patient case-based webinar you will have the opportunity to explore the central aims of the NHS Long Term Plan to improve CVD prevention and management, with the goal of improving quality of care for patients at risk of CV events.
Based on literature, we now have a better understanding of the impact of atrial fibrillation on morbidity and mortality, relevant to CVD and renal disease. 3 As such, this webinar will look at the practical implementation of the guidelines in a holistic way implementing the Detect, Protect and Perfect national agenda on Stroke prevention in Atrial Fibrillation.
1. https://www.bhf.org.uk/what-we-do/our-research/heart-statistics Accessed May 2022
2. https://ukhsa.blog.gov.uk/2021/02/12/cardiovascular-disease-building-back-better/ Accessed May 2022
3. Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG, Emdin CA. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ 2016;354:i4482. https://doi.org/10.1136/bmj.i4482
Professor Ahmet Fuat Professor Ahmet Fuat was a GP in Darlington, County Durham for 37 years, serving as CVD and Research Lead for the Darlington Primary Care Network and GP Federation. He became Medical Director at Oberoi Consulting in 2023 and will soon begin an Honorary Consultant Lipidologist/GPSI role with the diabetes and endocrinology team at County Durham and Darlington Foundation Trust.
A GPSI in Cardiology for over 25 years, he gained a Postgraduate Diploma in Cardiology from Bradford University with distinction and later tutored on the programme, teaching in heart failure (HF), valve disease, atrial fibrillation and ischaemic heart disease. In 2002, he helped establish the UK’s first one-stop diagnostic and integrated HF clinic. His PhD in HF diagnosis and management, including work on natriuretic peptides, produced influential publications and led to an Honorary Professorship at Durham University. He has contributed to NICE and ESC cardiovascular guidelines and the RCGP CKD/AKI toolkit.
Professor Fuat is the immediate past President of the Primary Care Cardiovascular Society (PCCS), now its Education and Research Lead, and serves as Lipid and HF Primary Care Lead for the North East and North Cumbria Academic Health Science Network. He is a member of the NHSE CVD Prevention Clinical Leadership Group and expert advisory groups for HF and heart valve disease, and a founder member of CaReMe UK.
Committed to medical education, he lectures widely, serves on editorial boards, and reviews for major cardiovascular journals. His contributions to community cardiology have been recognised with Fellowships from the RCGP, RCP London, RCP Edinburgh and the PCCS. At Oberoi, he oversees clinical development of digital disease-management platforms and mentors HF specialist nurses and clinical pharmacists.
This webinar will NOT be recorded due to the presentation being the Intellectual Property of the speakers.
The Zoom link to join the event will be emailed to the email address you booked with. This may be received into your spam/junk inboxes, please check.
If you cannot locate the Zoom link, please email webinar@mediconf.co.uk for assistance.
We no longer offer the option to dial in using your phone due to the excessive fees charged.
Find us on LINKEDIN
© Copyright 2007 - 2026 MediConf ©, Inc. All Rights Reserved ©
Registered Office: MediConf Uk c/o LCW Consulting, SWP, Suffolk House, George Street, Croydon, Surrey, CR0 0YN
Registered in England No. 09705397. Company registered in England and Wales. VAT Registration Number: 219014242
Telephone: 01444 414 264
Website design & development by Dual Media Ltd
This site is intended for use by UK healthcare professionals.
Please select the appropriate option below.